Clinical Trials Browser

olaparib × Dermatologic × Clear all

NCT05524935 2026-01-08

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Phase 2 Recruiting

Uveal Melanoma

NCT05482074 2024-01-19

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Phase 2 Withdrawn

Uveal Melanoma, Melanoma

NCT00516802 2009-05-15

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Phase 1 Completed

Melanoma Neoplasms